Gene · 6240
Papers3,003
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,003
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| In vitro and in silico study of the synergistic anticancer effect of alpinumisoflavone with gemcitabine on pancreatic ductal adenocarcinoma through suppression of ribonucleotide reductase subunit-M1. | Eur J Pharm Sci | 2025 | 39577749 | PubTator, text mining | PubMed |
| Identifying ribonucleotide reductase subunit genes as potential lung adenocarcinomas biomarkers using integrated bioinformatics analysis. | Malawi Med J | 2024 | 40191558 | PubTator, text mining | PubMed |
| hnRNPH1 Inhibits Influenza Virus Replication by Binding Viral RNA. | Microorganisms | 2024 | 39858792 | PubTator, text mining | PubMed |
| A simulation study on the process design and optimization pressure swing separation of azeotropic mixture methanol and toluene. | PLoS One | 2024 | 39715224 | PubTator, text mining | PubMed |
| RRM1 promotes homologous recombination and radio/chemo-sensitivity via enhancing USP11 and E2F1-mediated RAD51AP1 transcription. | Cell Death Discov | 2024 | 39695160 | PubTator, text mining | PubMed |
| A glutamine metabolish-associated prognostic model to predict prognosis and therapeutic responses of hepatocellular carcinoma. | Biol Direct | 2024 | 39563436 | PubTator, text mining | PubMed |
| Pathological Mutations D169G and P112H Electrostatically Aggravate the Amyloidogenicity of the Functional Domain of TDP-43. | ACS Chem Neurosci | 2024 | 39558635 | PubTator, text mining | PubMed |
| SNPs and blood inflammatory marker featured machine learning for predicting the efficacy of fluorouracil-based chemotherapy in colorectal cancer. | Sci Rep | 2024 | 39532939 | PubTator, text mining | PubMed |
| Insights into the Mode and Mechanism of Interactions Between RNA and RNA-Binding Proteins. | Int J Mol Sci | 2024 | 39518890 | PubTator, text mining | PubMed |
| Loss of Diphthamide Increases DNA Replication Stress in Mammalian Cells by Modulating the Translation of RRM1. | ACS Cent Sci | 2024 | 39463834 | PubTator, text mining | PubMed |
| A coarse-grained model for disordered and multi-domain proteins. | Protein Sci | 2024 | 39412378 | PubTator, text mining | PubMed |
| Comprehensive proteomics analysis reveals novel Nek2-regulated pathways and therapeutic targets in cancer. | Biochem Biophys Res Commun | 2024 | 39368370 | PubTator, text mining | PubMed |
| Creation of de novo cryptic splicing for ALS and FTD precision medicine. | Science | 2024 | 39361759 | PubTator, text mining | PubMed |
| RNA binding tunes the conformational plasticity and intradomain stability of TDP-43 tandem RNA recognition motifs. | Biophys J | 2024 | 39354713 | PubTator, text mining | PubMed |
| Fluorophore-quencher complexes (Cu2+/Al3+) of coumarin Schiff bases as chemosensors for the detection of L-glutamic acid and L-arginine: in vitro and in vivo studies. | Dalton Trans | 2024 | 39351607 | PubTator, text mining | PubMed |
| N-Terminal Fragments of TDP-43-In Vitro Analysis and Implication in the Pathophysiology of Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration. | Genes (Basel) | 2024 | 39336748 | PubTator, text mining | PubMed |
| Defining the mode of action of cisplatin combined with NUC-1031, a phosphoramidate modification of gemcitabine. | Transl Oncol | 2024 | 39299019 | PubTator, text mining | PubMed |
| YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic cancer. | Cancer Lett | 2024 | 39216548 | PubTator, text mining | PubMed |
| N-terminal domain of polypyrimidine-tract binding protein is a dynamic folding platform for adaptive RNA recognition. | Nucleic Acids Res | 2024 | 39180402 | PubTator, text mining | PubMed |
| Structural basis for RNA recognition by the C-terminal RRM domain of human RBM45. | J Biol Chem | 2024 | 39122006 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6240/papers?page=5